Hyaluronectin (HN) is a component of the extracellular matrix of connective
tissue and is particularly associated with tumour inflammatory and connect
ive stroma reaction, where it co-localizes with hyaluronic acid (HA), The H
N/HA ratio has been suggested to be involved in tumour aggressivity and in
the atherosclerosis process. IL-10 has also been described in atherosclerot
ic lesions and in cancer. HN production was therefore investigated in vitro
in peripheral blood monocyte cell (PBMC) cultures, with and without bacter
ial lipolysaccharide (LPS) or interleukins (ILs) in the medium. HN was char
acterized in monocytic cell cytoplasm and in culture supernatants. Anti-IL-
10 antibody suppressed the LPS-stimulating effect on HN production. HN synt
hesis rate was greatly increased in IL-10-activated cultures while IL-4 and
IL-13, two other anti-inflammatory ILs, decreased HN release. In the prese
nce of IL-10, the IL-4 or II-13 inhibitory effect on HN synthesis was rever
sed. The results support the view that intratumoral release of IL-10 by mon
ocytes may induce local production of HN, In conjunction with the known abi
lity of HN to bind to HA, which is a cell migration and tumour invasion fac
ilitating factor, and to inhibit HA-induced angiogenesis, our findings sugg
est that HN may modulate the effect of HA on atherosclerosis, angiogenesis
and cancer development. (C) 1999 Academic Press.